Related Experiment Video
Updated: Aug 19, 2026

Mechanical Stimulation-induced Calcium Wave Propagation in Cell Monolayers: The Example of Bovine Corneal Endothelial Cells
Published on: July 16, 2013
Chronic effects of endothelin 1 and angiotensin II on gap junctions and intercellular communication in cardiac cells
Lioudmilla Polontchouk1, Berit Ebelt, Miriam Jackels
1Institute of Pharmacology, Martin Luther University of Halle-Wittenberg, D-06097 Halle, Germany.
Insights
Endothelin-1 and angiotensin-II increase connexin43 expression and gap junctional communication in heart cells. These effects are mediated by specific receptors and involve mitogen-activated protein kinase pathways, influencing cardiac function.
Area of Science:
- Cardiovascular Biology
- Cellular Physiology
- Molecular Cardiology
Background:
- Endothelin-1 (ET-1) and angiotensin-II (AT-II) are key players in cardiovascular disease pathophysiology.
- Gap junctional communication is crucial for heart function and injury response.
Purpose of the Study:
- To investigate the effects of ET-1 and AT-II on connexin43 (Cx43) and connexin40 (Cx40) in cardiomyocytes.
- To elucidate the role of mitogen-activated protein kinase (MAPK) signaling in these responses.
Main Methods:
- Cultured neonatal rat ventricular cardiomyocytes (NRCs) were treated with ET-1 or AT-II.
- Connexin expression and phosphorylation were analyzed.
- Receptor antagonists (BQ123, BQ788, losartan) and MAPK inhibitors were used.
- Gap junctional conductance was measured via dual-cell voltage clamp.
Main Results:
- Both ET-1 and AT-II increased Cx43 expression and phosphorylation in a dose-dependent manner.
- ET-1 effects were blocked by ETA antagonists, and AT-II effects by AT1 antagonists.
- Cx40 expression remained unchanged, indicating differential regulation.
- ET-1 and AT-II enhanced gap junctional conductance.
- ERK1/2 mediated ET-1's effect on Cx43, while ERK and p38 pathways were involved in AT-II's regulation.
Conclusions:
- ET-1 and AT-II differentially regulate Cx43 and Cx40 in cardiomyocytes.
- ETA and AT1 receptor stimulation activates MAPK pathways (ERK, p38) to modulate cardiac gap junction function.
- These pathways are involved in regulating cardiac gap junctions under physiological and pathological conditions.
Abstract:
Endothelin-1 (ET-1) and angiotensin-II (AT-II) participate in the pathophysiology of cardiovascular diseases. Regulation of gap junctional intercellular communication may influence heart function and its response to cardiac injury. In this study, we examined the effects of ET-1 and AT-II on connexin43 (Cx43) and connexin40 (Cx40) in cultured neonatal rat ventricular cardiomyocytes (NRCs) and the role of mitogen-activated protein kinase signaling in the ET-1- and AT-II-induced responses. NRCs were incubated for 24 h with either ET-1 or AT-II (each at concentrations ranging from 10 to 1000 nM), and Cx43 expression and phosphorylation increased with increasing concentrations of both. ET-1 effects were significantly blocked by ETA (BQ123), but not by ETB (BQ788), receptor antagonists. AT-II-induced Cx43 induction could be completely inhibited by the AT1 receptor antagonist losartan. In contrast to Cx43, Cx40 expression did not change in either ET-1- or in AT-II-treated NRCs. Thus, these two connexins were differentially regulated. ET-1 and AT-II increased the gap junctional conductance between the cardiomyocytes in culture as measured using a dual-cell voltage clamp. Mitogen-activated protein kinase inhibition revealed that ERK1/2 was critical for up-regulation of Cx43 in response to ET-1, whereas both ERK and p38 signal pathways were involved in the regulation of Cx43 by AT-II. Thus, stimulation of the ERK and p38 signal pathways via ETA and AT1 receptors may partcipate in the regulation of cardiac gap junctions under (patho)physiological conditions.
Related Concept Videos
Gap Junctions
Overview of Cell-Matrix Interactions
Intracellular Signaling Affects Focal Adhesions
Some...
Overview of Cell-Cell Junctions
Occluding or Tight Junctions
Tight...
Gap Junctions
Heart Failure II: Pathophysiology

